These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 15062168)
1. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168 [TBL] [Abstract][Full Text] [Related]
2. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780 [TBL] [Abstract][Full Text] [Related]
3. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer. Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661 [TBL] [Abstract][Full Text] [Related]
4. High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue. Tendulkar RD; Fleming PA; Reddy CA; Gildea TR; Machuzak M; Mehta AC Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):701-6. PubMed ID: 17904764 [TBL] [Abstract][Full Text] [Related]
5. [High dose endobronchial brachytherapy for malignant airway obstruction: first study of 30 patients]. Yarmolovsky A; Katz A; Fenig E; Fink G; Bendayan D; Sulkes A; Kramer MR Harefuah; 2000 Mar; 138(6):429-31, 520. PubMed ID: 10883152 [TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
7. High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions. Petera J; Spásová I; Neumanová R; Skricková J; Salajka F; Hrazdírová A; Kaplanová J; Coupková H; Coupek P; Kucera M Neoplasma; 2001; 48(2):148-53. PubMed ID: 11478697 [TBL] [Abstract][Full Text] [Related]
8. HDR intraluminal brachytherapy in the treatment of malignant bronchial obstructions. Petera J; Neumanová R; Vrba M; Coupek P; Salajka F; Hrazdírová A; Kucera M; Snízek T; Kolman P; Hanák V Neoplasma; 2000; 47(1):56-9. PubMed ID: 10870688 [TBL] [Abstract][Full Text] [Related]
9. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions. Spásová I; Petera J Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of endobronchial brachytherapy: A curative treatment? Hennequin C; Bleichner O; Trédaniel J; Quero L; Sergent G; Zalcman G; Maylin C Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):425-30. PubMed ID: 17084547 [TBL] [Abstract][Full Text] [Related]
11. High-dose-rate (HDR) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue. Madu CN; Machuzak MS; Sterman DH; Musani A; Ahya V; McDonough J; Metz JM Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1450-6. PubMed ID: 16997502 [TBL] [Abstract][Full Text] [Related]
12. [Brachytherapy: endobronchial irradiation for primary and secondary bronchial tumors]. Kramer MR; Berkman N; Weshler Z Harefuah; 1992 Jun; 122(12):760-3, 820. PubMed ID: 1380474 [TBL] [Abstract][Full Text] [Related]
13. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis. Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149 [TBL] [Abstract][Full Text] [Related]
14. [Brachytherapy in the treatment of lung and tracheal cancer: current indications, methods, results]. Skowronek J; Młynarczyk W; Piorunek T Przegl Lek; 2006; 63(8):664-73. PubMed ID: 17441380 [TBL] [Abstract][Full Text] [Related]
15. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839 [TBL] [Abstract][Full Text] [Related]
17. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). Weinberg BD; Allison RR; Sibata C; Parent T; Downie G Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):50-8. PubMed ID: 20230994 [TBL] [Abstract][Full Text] [Related]
18. Endobronchial brachytherapy in combination with external beam irradiation in obstructing malignant bronchial tumors. Prévost A; Berthiot G; Picavet B; Froissart D; Loirette M; Costa B; Cauchois A; Nguyen TD Oncol Rep; 2003; 10(4):921-5. PubMed ID: 12792746 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
20. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]